Correction: Exploring s-triazine derivatives as anticancer agents
Sections
Open Access Correction
Correction: Exploring s-triazine derivatives as anticancer agents

Affiliation:

1Peptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4000, South Africa

Email: Sharmaa@ukzn.ac.za

ORCID: https://orcid.org/0000-0003-1282-5838

Anamika Sharma
1*

Affiliation:

2Department of Math and Sciences, College of Humanities and Sciences, Prince Sultan University, Riyadh 11586, Saudi Arabia

ORCID: https://orcid.org/0000-0002-7988-7358

Ihab Shawish
2

Affiliation:

1Peptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4000, South Africa

3School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa

ORCID: https://orcid.org/0000-0001-5632-2293

Ashish Kumar
1,3

Affiliation:

3School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa

ORCID: https://orcid.org/0000-0001-8521-9172

Beatriz G. de la Torre
3

Affiliation:

1Peptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Durban 4000, South Africa

4Department of Inorganic and Organic Chemistry, University of Barcelona, 08193 Barcelona, Spain

Email: Albericio@ukzn.ac.za

ORCID: https://orcid.org/0000-0002-8946-0462

Fernando Albericio
1,4*

Affiliation:

5Department of Basic Medical Sciences, College of Medicine, Dar Al Uloom University, Riyadh 11512, Saudi Arabia

6Department of Chemistry, Faculty of Science, Alexandria University, Alexandria 21321, Egypt

Email: ayman.a@dau.edu.sa

ORCID: https://orcid.org/0000-0002-3951-2754

Ayman El-Faham
5,6*

Explor Drug Sci. 2026;4:1008153 DOI: https://doi.org/10.37349/eds.2026.1008153

Received: Accepted: Published: March 02, 2026

Correction to “Exploring s-triazine derivatives as anticancer agents” by Sharma A, Shawish I, Kumar A, de la Torre BG, Albericio F, El-Faham A. Explor Drug Sci. 2026;4:1008149. DOI: 10.37349/eds.2026.1008149

The authors have recognized an error in the published paper:

Figure 6 inaccurately gives the synthesis pathway and is replaced here with the corrected figure. The corrected figure clearly depicts a two-step synthesis pathway from the primary alcohol to the target heterocycle, compound 4. The corrected version of the figure is provided below.

MW-assisted synthesis of s-triazine derivatives (4). MW: microwave irradiation.

This correction does not affect the scientific content, interpretation of the results, or the conclusions of the paper. The authors apologize for any inconvenience caused to the readers by this error.

The original uncorrected PDF can be accessed from https://www.explorationpub.com//uploads/Article/A1008149/1008149.pdf

Cite this Article
Export Citation
Sharma A, Shawish I, Kumar A, de la Torre BG, Albericio F, El-Faham A. Correction: Exploring s-triazine derivatives as anticancer agents. Explor Drug Sci. 2026;4:1008153. https://doi.org/10.37349/eds.2026.1008153
Article Metrics

View: 65

Download: 7

Times Cited: 0